The global Extracellular Matrix Market Growth Accelerated by Rise in Orthopedic and Wound Healing Applications

The global Extracellular Matrix Market is estimated to be valued at US$ 46.12 Bn in 2023 and is expected to exhibit a CAGR of 9.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Extracellular matrix (ECM) is found throughout the human body. It provides structural support to surrounding cells and plays an important role in coordinating cellular behavior. ECM products available in the market mimic the body's own ECM and support tissue regeneration and wound healing. ECM is used in various orthopedic, general surgery, gynecology, and urology applications.


Market key trends:
The key trend accelerating the growth of the extracellular matrix market size is the increasing applications of ECM in the field of orthopedics and wound healing. Extracellular matrices are finding widespread use in various orthopedic procedures such as hernia repair, rotator cuff repair, cartilage repair, and breast reconstruction. Studies have shown that ECM derived scaffolds stimulate wound healing by enhancing re-epithelialization, granulation tissue formation, angiogenesis, and decreasing inflammation. They also act as a template by promoting the migration, proliferation, and differentiation of cells involved in wound healing. Rising demand for advanced wound care options and favorable reimbursement policies for ECM products are boosting their adoption in wound management applications.

Segment Analysis
The global extracellular matrix market can be segmented based on application, product type, composition, material, and end user. By application, the reconstructive segment dominated the market in 2023 due to the increasing prevalence of wounds globally. Sub-segment reconstructive includes soft tissue repair, hernia repair, breast reconstruction, and dural repair.

Key Takeaways
The global extracellular matrix market is expected to witness high growth during the forecast period of 2023-2030.

Regional Analysis
North America dominated the global extracellular matrix market in 2023 due to the rising prevalence of chronic diseases and rapid technological advancements in the region. Moreover, the presence of key players and robust research activities fuel market growth in North America.

Key players
Key players operating in the extracellular matrix market are Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, MIMETAS.

Comments

Popular posts from this blog

The global Ion Exchange Membrane Market Growth Accelerated by Increasing Industrialization and Urbanization

Healthcare IT (HCIT) is fastest growing segment fueling the growth of Drug for Abuse Testing Devices Market

Electric Powertrain Market Growth Accelerated by Adoption of Stringent Emission Regulations